.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Leveraging Immunotherapy in GI Malignancies

In this series of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, Sunil Sharma, MD, and Madappa Kundranda, MD, PhD, discuss early detection with multiomic assays and leveraging immunotherapy in gastrointestinal cancers.

EP. 1: Leveraging Immunotherapy in GI Malignancies: Is Multicancer Early Detection Becoming a Reality?

March 29th 2024

In this episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts discuss the potential for early detection multiomic assays and the work that still needs to be done to encourage their widespread use.

EP. 2: Leveraging Immunotherapy in GI Malignancies: Assays for Early Detection and Prevention

March 29th 2024

In this episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts explain the challenges faced with preventing or detecting these cancers early and the understanding needed to develop effective early detection methods and move the needle forward.

Leveraging Immunotherapy in GI Malignancies

EP. 1: Leveraging Immunotherapy in GI Malignancies: Is Multicancer Early Detection Becoming a Reality?

EP. 2: Leveraging Immunotherapy in GI Malignancies: Assays for Early Detection and Prevention

EP. 3: Leveraging Immunotherapy in GI Malignancies: A Shift in Drug Discovery

EP. 4: Leveraging Immunotherapy in GI Malignancies: Research, Including Organoids and Ablation

EP. 5: Leveraging Immunotherapy in GI Malignancies: Looking to the Future